Deep Track Biotechnology Master Fund, Ltd. (CIK 2015536) reported 7 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-08-10). Recent activity: Buy ATTO (2.0M shares), Sell DVAX (15.7M shares), Buy LBRX (686,138 shares), Buy LBRX (2.0M shares), Buy LBRX (666,666 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Attovia Therapeutics, Inc. (ATTO) | 10% Owner | Buy | 2.0M | $0 |
| 2026-02-11 | DYNAVAX TECHNOLOGIES CORP (DVAX) | 10% Owner | Sell | 15.7M | $0 |
| 2025-09-16 | LB PHARMACEUTICALS INC (LBRX) | 10% Owner | Buy | 686,138 | $0 |
| 2025-09-16 | LB PHARMACEUTICALS INC (LBRX) | 10% Owner | Buy | 2.0M | $30.0M |
| 2025-09-16 | LB PHARMACEUTICALS INC (LBRX) | 10% Owner | Buy | 666,666 | $10.0M |
| 2025-08-22 | DYNAVAX TECHNOLOGIES CORP (DVAX) | 10% Owner | Sell | 1.1M | $12.1M |
| 2025-08-22 | DYNAVAX TECHNOLOGIES CORP (DVAX) | 10% Owner | Sell | 970,143 | $10.3M |
来源：SEC Form 4 申报文件 · 截至 2026-08-10